Hansoh Pharmaceutical Group Company Limited (stock code: 03692) reported that its authorized share capital remained unchanged at 20,000,000,000 ordinary shares with a par value of HKD 0.00001 each, totaling HKD 200,000. The number of issued shares was 6,055,150,070 with no treasury shares, showing no change compared to the previous month. The public float requirement of 16.21% was met as of the end of January 2026.

The zero coupon convertible bonds due 2026 with an outstanding principal amount of USD 5,378,000 matured during the period. The bonds carried a subscription/conversion price of HKD 56.7 and were listed under stock code 40546. No new shares were issued pursuant to the maturity of these convertibles, and no other issuance or repurchase activities were recorded.